Tonsillectomy Improved Therapeutic Response in Anti-SRP Myopathy With Chronic Tonsillitis.
IgA nephritis
anti-SRP myopathy
chronic tonsillitis
intravenous immunoglobulin
tonsillectomy
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2020
2020
Historique:
received:
16
08
2020
accepted:
28
10
2020
entrez:
17
12
2020
pubmed:
18
12
2020
medline:
10
7
2021
Statut:
epublish
Résumé
Chronic tonsillitis has been attracted attention as a source of abnormal immune responses and a possible trigger of autoimmune diseases such as IgA nephritis, IgA vasculitis, palmoplantar pustulosis, psoriasis, rheumatoid arthritis, Behçet's disease, and myositis. Here we present the first report of anti-signal recognition particle antibody-associated necrotizing myopathy (anti-SRP myopathy) with IgA nephropathy and chronic tonsillitis in which the therapeutic response to intravenous immunoglobulin (IVIG) treatment was dramatically improved after tonsillectomy and accompanied by a rapid increase in ΔIgG, defined as the change in serum IgG levels 2 weeks after the start of IVIG treatment relative to pre-treatment levels. Moreover, serum anti-SRP antibody titers became undetectable after tonsillectomy even though the resected tonsils did not produce anti-SRP antibodies. Tonsillectomy should be considered when chronic tonsillitis is observed in patients with autoimmune diseases showing poor response to treatment, including anti-SRP myopathy.
Identifiants
pubmed: 33329585
doi: 10.3389/fimmu.2020.595480
pmc: PMC7732549
doi:
Substances chimiques
Immunoglobulins, Intravenous
0
Signal Recognition Particle
0
Types de publication
Case Reports
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
595480Informations de copyright
Copyright © 2020 Ikeda, Takeuchi, Takahashi, Nakamura, Kunii, Katsumoto, Tada, Higashiyama, Hibiya, Suzuki, Nishino, Koyano, Doi and Tanaka.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Orphanet J Rare Dis. 2015 May 13;10:61
pubmed: 25963141
J Nephrol. 2016 Feb;29(1):13-9
pubmed: 26582216
Neuromuscul Disord. 2018 Jan;28(1):87-99
pubmed: 29221629
Nat Med. 2019 Dec;25(12):1822-1832
pubmed: 31806905
Ann Neurol. 2009 Nov;66(5):597-603
pubmed: 19938102
Am J Kidney Dis. 2015 Jan;65(1):80-7
pubmed: 25446024
Kidney Int. 2004 Apr;65(4):1135-44
pubmed: 15086452
Nat Rev Nephrol. 2012 Mar 20;8(5):275-83
pubmed: 22430056
Immun Inflamm Dis. 2019 Jun;7(2):86-93
pubmed: 30957421
Acta Otolaryngol Suppl. 1993;508:36-42
pubmed: 8285041
Nephron. 1996;74(2):301-8
pubmed: 8893145
Nephrol Dial Transplant. 2013 Dec;28(12):3004-13
pubmed: 24081865